Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]

by Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Published 2014

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

by Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Published 2013

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

by Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Published 2018

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

by Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Published 2014

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

by Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F
Published 2018

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

by Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F
Published 2017